Role of prostaglandin E2 in tissue repair and regeneration

Tissue regeneration following injury from disease or medical treatment still represents a challenge in regeneration medicine. Prostaglandin E2 (PGE2), which involves diverse physiological processes via E-type prostanoid (EP) receptor family, favors the regeneration of various organ systems following...

Full description

Saved in:
Bibliographic Details
Published in:Theranostics 2021-01, Vol.11 (18), p.8836-8854
Main Authors: Cheng, Hui, Huang, Haoyan, Guo, Zhikun, Chang, Ying, Li, Zongjin
Format: Article
Language:English
Subjects:
Angiogenesis
Animals
Diabetes
Dinoprostone - metabolism
Dinoprostone - physiology
Fibroblasts
Genotype & phenotype
Humans
Hydrogels
Inflammation
Ischemia
Nonsteroidal anti-inflammatory drugs
Physiology
Regeneration - physiology
Review
Scars
Signal Transduction - drug effects
Skin
Tissue engineering
Wound healing
Wound Healing - physiology
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c472t-146f9b0e88832df21097d48ecc99f022ab755aca8cee57d7c9fec3a7184dabf13
cites
container_end_page 8854
container_issue 18
container_start_page 8836
container_title Theranostics
container_volume 11
creator Cheng, Hui
Huang, Haoyan
Guo, Zhikun
Chang, Ying
Li, Zongjin
description Tissue regeneration following injury from disease or medical treatment still represents a challenge in regeneration medicine. Prostaglandin E2 (PGE2), which involves diverse physiological processes via E-type prostanoid (EP) receptor family, favors the regeneration of various organ systems following injury for its capabilities such as activation of endogenous stem cells, immune regulation, and angiogenesis. Understanding how PGE2 modulates tissue regeneration and then exploring how to elevate the regenerative efficiency of PGE2 will provide key insights into the tissue repair and regeneration processes by PGE2. In this review, we summarized the application of PGE2 to guide the regeneration of different tissues, including skin, heart, liver, kidney, intestine, bone, skeletal muscle, and hematopoietic stem cell regeneration. Moreover, we introduced PGE2-based therapeutic strategies to accelerate the recovery of impaired tissue or organs, including 15-hydroxyprostaglandin dehydrogenase (15-PGDH) inhibitors boosting endogenous PGE2 levels and biomaterial scaffolds to control PGE2 release.
doi_str_mv 10.7150/thno.63396
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8419039</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2598193022</sourcerecordid><originalsourceid>FETCH-LOGICAL-c472t-146f9b0e88832df21097d48ecc99f022ab755aca8cee57d7c9fec3a7184dabf13</originalsourceid><addsrcrecordid>eNpdkU1LAzEQhoMottRe_AGy4EWE1nztJvEgSKkfUBBEzyHNzrZbtps12RX896a2luocZgbm4WVmXoTOCR4LkuKbdlm7ccaYyo5Qn0gmRyLj-Pig76FhCCscg2OqiDpFPcZTSinhfXT76ipIXJE03oXWLCpT52WdTGkSc1uG0EHioTGlT-IktguowZu2dPUZOilMFWC4qwP0_jB9mzyNZi-Pz5P72chyQdsR4Vmh5hiklIzmBSVYiZxLsFapAlNq5iJNjTXSAqQiF1YVYJkRRPLczAvCBuhuq9t08zXkFurWm0o3vlwb_6WdKfXfSV0u9cJ9asmJwkxFgaudgHcfHYRWr8tgoYq3guuCpqmgimGJWUQv_6Er1_k6nhcpJUnEKI3U9Zay8WnBQ7FfhmC9cUVvXNE_rkT44nD9PfrrAfsGMUmIUw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2598193022</pqid></control><display><type>article</type><title>Role of prostaglandin E2 in tissue repair and regeneration</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><creator>Cheng, Hui ; Huang, Haoyan ; Guo, Zhikun ; Chang, Ying ; Li, Zongjin</creator><creatorcontrib>Cheng, Hui ; Huang, Haoyan ; Guo, Zhikun ; Chang, Ying ; Li, Zongjin</creatorcontrib><description>Tissue regeneration following injury from disease or medical treatment still represents a challenge in regeneration medicine. Prostaglandin E2 (PGE2), which involves diverse physiological processes via E-type prostanoid (EP) receptor family, favors the regeneration of various organ systems following injury for its capabilities such as activation of endogenous stem cells, immune regulation, and angiogenesis. Understanding how PGE2 modulates tissue regeneration and then exploring how to elevate the regenerative efficiency of PGE2 will provide key insights into the tissue repair and regeneration processes by PGE2. In this review, we summarized the application of PGE2 to guide the regeneration of different tissues, including skin, heart, liver, kidney, intestine, bone, skeletal muscle, and hematopoietic stem cell regeneration. Moreover, we introduced PGE2-based therapeutic strategies to accelerate the recovery of impaired tissue or organs, including 15-hydroxyprostaglandin dehydrogenase (15-PGDH) inhibitors boosting endogenous PGE2 levels and biomaterial scaffolds to control PGE2 release.</description><identifier>ISSN: 1838-7640</identifier><identifier>EISSN: 1838-7640</identifier><identifier>DOI: 10.7150/thno.63396</identifier><identifier>PMID: 34522214</identifier><language>eng</language><publisher>Australia: Ivyspring International Publisher Pty Ltd</publisher><subject>Angiogenesis ; Animals ; Diabetes ; Dinoprostone - metabolism ; Dinoprostone - physiology ; Fibroblasts ; Genotype &amp; phenotype ; Humans ; Hydrogels ; Inflammation ; Ischemia ; Nonsteroidal anti-inflammatory drugs ; Physiology ; Regeneration - physiology ; Review ; Scars ; Signal Transduction - drug effects ; Skin ; Tissue engineering ; Wound healing ; Wound Healing - physiology</subject><ispartof>Theranostics, 2021-01, Vol.11 (18), p.8836-8854</ispartof><rights>The author(s).</rights><rights>2021. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The author(s) 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c472t-146f9b0e88832df21097d48ecc99f022ab755aca8cee57d7c9fec3a7184dabf13</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2598193022/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2598193022?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,313,314,727,780,784,792,885,25753,27922,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34522214$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cheng, Hui</creatorcontrib><creatorcontrib>Huang, Haoyan</creatorcontrib><creatorcontrib>Guo, Zhikun</creatorcontrib><creatorcontrib>Chang, Ying</creatorcontrib><creatorcontrib>Li, Zongjin</creatorcontrib><title>Role of prostaglandin E2 in tissue repair and regeneration</title><title>Theranostics</title><addtitle>Theranostics</addtitle><description>Tissue regeneration following injury from disease or medical treatment still represents a challenge in regeneration medicine. Prostaglandin E2 (PGE2), which involves diverse physiological processes via E-type prostanoid (EP) receptor family, favors the regeneration of various organ systems following injury for its capabilities such as activation of endogenous stem cells, immune regulation, and angiogenesis. Understanding how PGE2 modulates tissue regeneration and then exploring how to elevate the regenerative efficiency of PGE2 will provide key insights into the tissue repair and regeneration processes by PGE2. In this review, we summarized the application of PGE2 to guide the regeneration of different tissues, including skin, heart, liver, kidney, intestine, bone, skeletal muscle, and hematopoietic stem cell regeneration. Moreover, we introduced PGE2-based therapeutic strategies to accelerate the recovery of impaired tissue or organs, including 15-hydroxyprostaglandin dehydrogenase (15-PGDH) inhibitors boosting endogenous PGE2 levels and biomaterial scaffolds to control PGE2 release.</description><subject>Angiogenesis</subject><subject>Animals</subject><subject>Diabetes</subject><subject>Dinoprostone - metabolism</subject><subject>Dinoprostone - physiology</subject><subject>Fibroblasts</subject><subject>Genotype &amp; phenotype</subject><subject>Humans</subject><subject>Hydrogels</subject><subject>Inflammation</subject><subject>Ischemia</subject><subject>Nonsteroidal anti-inflammatory drugs</subject><subject>Physiology</subject><subject>Regeneration - physiology</subject><subject>Review</subject><subject>Scars</subject><subject>Signal Transduction - drug effects</subject><subject>Skin</subject><subject>Tissue engineering</subject><subject>Wound healing</subject><subject>Wound Healing - physiology</subject><issn>1838-7640</issn><issn>1838-7640</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkU1LAzEQhoMottRe_AGy4EWE1nztJvEgSKkfUBBEzyHNzrZbtps12RX896a2luocZgbm4WVmXoTOCR4LkuKbdlm7ccaYyo5Qn0gmRyLj-Pig76FhCCscg2OqiDpFPcZTSinhfXT76ipIXJE03oXWLCpT52WdTGkSc1uG0EHioTGlT-IktguowZu2dPUZOilMFWC4qwP0_jB9mzyNZi-Pz5P72chyQdsR4Vmh5hiklIzmBSVYiZxLsFapAlNq5iJNjTXSAqQiF1YVYJkRRPLczAvCBuhuq9t08zXkFurWm0o3vlwb_6WdKfXfSV0u9cJ9asmJwkxFgaudgHcfHYRWr8tgoYq3guuCpqmgimGJWUQv_6Er1_k6nhcpJUnEKI3U9Zay8WnBQ7FfhmC9cUVvXNE_rkT44nD9PfrrAfsGMUmIUw</recordid><startdate>20210101</startdate><enddate>20210101</enddate><creator>Cheng, Hui</creator><creator>Huang, Haoyan</creator><creator>Guo, Zhikun</creator><creator>Chang, Ying</creator><creator>Li, Zongjin</creator><general>Ivyspring International Publisher Pty Ltd</general><general>Ivyspring International Publisher</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210101</creationdate><title>Role of prostaglandin E2 in tissue repair and regeneration</title><author>Cheng, Hui ; Huang, Haoyan ; Guo, Zhikun ; Chang, Ying ; Li, Zongjin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c472t-146f9b0e88832df21097d48ecc99f022ab755aca8cee57d7c9fec3a7184dabf13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Angiogenesis</topic><topic>Animals</topic><topic>Diabetes</topic><topic>Dinoprostone - metabolism</topic><topic>Dinoprostone - physiology</topic><topic>Fibroblasts</topic><topic>Genotype &amp; phenotype</topic><topic>Humans</topic><topic>Hydrogels</topic><topic>Inflammation</topic><topic>Ischemia</topic><topic>Nonsteroidal anti-inflammatory drugs</topic><topic>Physiology</topic><topic>Regeneration - physiology</topic><topic>Review</topic><topic>Scars</topic><topic>Signal Transduction - drug effects</topic><topic>Skin</topic><topic>Tissue engineering</topic><topic>Wound healing</topic><topic>Wound Healing - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cheng, Hui</creatorcontrib><creatorcontrib>Huang, Haoyan</creatorcontrib><creatorcontrib>Guo, Zhikun</creatorcontrib><creatorcontrib>Chang, Ying</creatorcontrib><creatorcontrib>Li, Zongjin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Theranostics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cheng, Hui</au><au>Huang, Haoyan</au><au>Guo, Zhikun</au><au>Chang, Ying</au><au>Li, Zongjin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of prostaglandin E2 in tissue repair and regeneration</atitle><jtitle>Theranostics</jtitle><addtitle>Theranostics</addtitle><date>2021-01-01</date><risdate>2021</risdate><volume>11</volume><issue>18</issue><spage>8836</spage><epage>8854</epage><pages>8836-8854</pages><issn>1838-7640</issn><eissn>1838-7640</eissn><abstract>Tissue regeneration following injury from disease or medical treatment still represents a challenge in regeneration medicine. Prostaglandin E2 (PGE2), which involves diverse physiological processes via E-type prostanoid (EP) receptor family, favors the regeneration of various organ systems following injury for its capabilities such as activation of endogenous stem cells, immune regulation, and angiogenesis. Understanding how PGE2 modulates tissue regeneration and then exploring how to elevate the regenerative efficiency of PGE2 will provide key insights into the tissue repair and regeneration processes by PGE2. In this review, we summarized the application of PGE2 to guide the regeneration of different tissues, including skin, heart, liver, kidney, intestine, bone, skeletal muscle, and hematopoietic stem cell regeneration. Moreover, we introduced PGE2-based therapeutic strategies to accelerate the recovery of impaired tissue or organs, including 15-hydroxyprostaglandin dehydrogenase (15-PGDH) inhibitors boosting endogenous PGE2 levels and biomaterial scaffolds to control PGE2 release.</abstract><cop>Australia</cop><pub>Ivyspring International Publisher Pty Ltd</pub><pmid>34522214</pmid><doi>10.7150/thno.63396</doi><tpages>19</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1838-7640
ispartof Theranostics, 2021-01, Vol.11 (18), p.8836-8854
issn 1838-7640
1838-7640
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8419039
source Open Access: PubMed Central; Publicly Available Content Database
subjects Angiogenesis
Animals
Diabetes
Dinoprostone - metabolism
Dinoprostone - physiology
Fibroblasts
Genotype & phenotype
Humans
Hydrogels
Inflammation
Ischemia
Nonsteroidal anti-inflammatory drugs
Physiology
Regeneration - physiology
Review
Scars
Signal Transduction - drug effects
Skin
Tissue engineering
Wound healing
Wound Healing - physiology
title Role of prostaglandin E2 in tissue repair and regeneration
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T06%3A12%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20prostaglandin%20E2%20in%20tissue%20repair%20and%20regeneration&rft.jtitle=Theranostics&rft.au=Cheng,%20Hui&rft.date=2021-01-01&rft.volume=11&rft.issue=18&rft.spage=8836&rft.epage=8854&rft.pages=8836-8854&rft.issn=1838-7640&rft.eissn=1838-7640&rft_id=info:doi/10.7150/thno.63396&rft_dat=%3Cproquest_pubme%3E2598193022%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c472t-146f9b0e88832df21097d48ecc99f022ab755aca8cee57d7c9fec3a7184dabf13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2598193022&rft_id=info:pmid/34522214&rfr_iscdi=true